Skip to content
naulon
Not checkedNot checked for notices yet.

Symposium 16: Clinical follow-up: new guidelines and consensus

Susana Apoloni

Revista de la Sociedad Argentina de Diabetes · 2022

doi:10.47196/diab.v56i3sup.634 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Immune-mediated diabetes in adults is a challenge in its diagnosis, as well as its differentiation from type 2 diabetes and LADA. In the follow-up and treatment of this population, an intensified insulin therapy is the ideal regimen of insulin replacement to reaches glycemic targets, in order to avoid the development and progression of macro and microvascular complications, minimizing episodes of hypoglycemia and providing strategies to ensure adequate quality of life with reduction of the psychosocial burden of living with diabetes. In addition to capillary glycemic self-monitoring and HbA1c, there are currently new technological tools: interstitial and real-time glucose sensors and new insulin analogs, integrated insulin infusion systems with sensor and closed hybrid systems.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.